Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
- Not stated
- Not stated
- Aug 31, 2026
Official announcement on grants_gov · opens the funder's page. Always confirm dates there.
Other topics in this solicitation
Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)
$400k
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
The rest of this announcement — free with an account
- The full announcement text, not the first two sentences
- The scoring framework for this mechanism — we have not extracted per-criterion detail for this specific announcement
- Whether you are eligible — career stage, institution type, and the windows that close before the deadline does
- What similar funded projects received, from 219,000 past awards
More from National Institutes of Health
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)
$350k
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
$250k
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
$350k